Archives
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Foretinib Evidence: Five Questions for Better Interpretation
2026-10-05
A source-grounded guide to interpreting Foretinib and GSK1363089 evidence, separating kinase mechanism, cancer-response metrics, model-specific findings, and the limits of preclinical translation.
-
Fluo-4 AM in Calcium Imaging and Retinal Research
2026-10-05
Fluo-4 AM is a fluorescent calcium indicator for tracking relative intracellular Ca2+ dynamics. This overview distinguishes supplier information from primary evidence and examines how calcium imaging could conceptually complement research on a reported ferroelectric-liquid-metal retinal prosthesis, while emphasizing methodological and translational limits.
-
GW4064: Evidence, Scope and FXR Signaling
2026-10-04
A source-grounded overview of GW4064 as a non-steroidal FXR agonist, examining its biological principle, evidence from a 2025 liver-cell study, interpretation of FXR/TLR4 and ferroptosis findings, and limits on broader translation.
-
NAD+ and Cellular Stress: Evidence and Limits
2026-10-03
Nicotinamide Adenine Dinucleotide (NAD+) links redox metabolism with enzyme activity and stress signaling, but recent findings on caspase-dependent autophagy do not establish a direct role for NAD+. This overview separates established NAD+ biochemistry from the findings, applications, and limitations of a 2025 study in human breast cancer cells.
-
Anlotinib Hydrochloride Assay Workflows
2026-10-02
This scenario-based guide explains how Anlotinib hydrochloride, SKU C8688, can improve interpretation and consistency in endothelial migration, tube formation, proliferation, and cytotoxicity assays. It connects reported nanomolar kinase activity with practical experimental design, optimization, comparison, and product-selection decisions.
-
Trolox Workflows for Oxidative Stress Assays
2026-10-01
Trolox combines practical cell permeability with a defined vitamin E analogue structure, making it useful as both an oxidative stress intervention and a positive control for antioxidant assays. This guide translates its solvent handling, dose design, lipid peroxidation readouts, and disease-model applications into reproducible bench workflows.
-
GSK126: Practical EZH2 Inhibitor Workflows
2026-10-01
GSK126 connects EZH2 target engagement with H3K27me3 loss, gene reactivation, and cancer-cell state changes. This workflow-focused guide shows how to apply it in lymphoma, EMT, combination-treatment, and broader cancer epigenetics research while avoiding common dosing and solubility errors.
-
AO/PI Double Staining Kit: Practical Workflow
2026-09-30
The AO/PI Double Staining Kit (SKU K2238) provides a rapid fluorescent cell viability assay that separates viable, apoptotic-like, and membrane-compromised cell populations using Acridine Orange and Propidium Iodide. It is intended for prepared cell suspensions or dispersed cells, not as a standalone method for intact-tissue imaging or definitive assignment of a cell-death pathway.
-
CA800-PR Targets Progesterone Signaling in Breast Cancer
2026-09-30
The reference study presents CA800-PR, a tumor-targeted heptamethine cyanine dye that combines near-infrared imaging with suppression of progesterone receptor activity in hormone receptor-positive breast cancer models. Its reported effects include Golgi fragmentation, apoptosis, inflammatory signaling, and increased MHC class II-positive, CD80-positive M1-type macrophages, suggesting a treatment concept that connects direct tumor stress with immune remodeling.
-
Perospirone: Receptor and Kv1.5 Assay Workflows
2026-09-29
Perospirone, also known as SM-9018 free base, supports mechanism-focused schizophrenia research while enabling a parallel investigation of vascular Kv1.5 channel modulation. This practical guide connects receptor pharmacology, patch-clamp experiments, concentration planning, and troubleshooting for neuropsychiatric and cardiovascular assay development.
-
GSK-923295 Workflows for Mitotic Precision
2026-09-29
GSK-923295 provides a selective way to connect CENP-E motor inhibition with chromosome congression, mitotic arrest, and tumor-cell response. This workflow guide combines dose-response design, live-cell imaging, centromere-focused assays, troubleshooting, and cautious translation to xenograft research.
-
NAT1–ENO1–Lactate Signaling in Colorectal Cancer
2026-09-28
A 2026 MedComm study identifies NAT1 as a metabolic–immune regulator that restrains ENO1 activity through acetylation, limits lactate production, and reduces PD-L1 stability in colorectal cancer. Its integrated patient, multi-omics, cellular, and mouse-model evidence suggests that disrupting the NAT1–ENO1–lactate–TRAF6 pathway may improve responses to PD-1 or PD-L1 blockade, while also defining important boundaries for future metabolism-focused experiments.
-
Cisapride in iPSC Cardiotoxicity Screens
2026-09-28
Use Cisapride (R 51619) as a mechanistically informative perturbation when pairing iPSC-derived cardiomyocytes with high-content imaging. This workflow connects hERG-related electrical risk and 5-HT4 signaling to phenotype screening, while emphasizing the orthogonal measurements needed to interpret each signal.
-
Meropenem Exposure–Response in Resistance Research
2026-09-27
Explore how Meropenem can serve as a controlled perturbation for studying exposure–response relationships and resistance in bacterial models. This guide connects its PBP-directed mechanism with assay design, practical handling, and careful interpretation of findings.
-
Angiotensin Peptides Enhance Spike–Receptor Binding
2026-09-26
Oliveira and colleagues report that several naturally occurring angiotensin peptides increase SARS-CoV-2 spike-protein binding to host receptors, with peptide length and sequence modifications shaping the effect. The findings identify a biochemical connection between renin–angiotensin signaling and viral receptor interactions, while leaving open whether enhanced binding changes infection in living cells or organisms.